Bench Press: BioWorld looks at translational medicine
Tuesday, February 18, 2014
KRAS is among the most frequently mutated genes in cancer. Now, researchers from New York University have found that in cells with mutated KRAS, the normal versions of two other members of the Ras family – HRAS and NRAS – contribute to the out-of-control growth of KRAS mutated cells.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.